Condition

Sedation in Intensive Care (3)

Overall Status

Completed (2)

Terminated (1)

Sign in for free

Phase

phase 3 (2)

phase 2 (1)

Sponsor

Haisco Pharmaceutical Group Co., Ltd. (2)

University of Erlangen-Nurnberg Medical School (1)

Intervention

hsk3486 (2)

propofol (2)

clonidine (1)

midazolam (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

sedation in intensive care

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Sedation in Intensive Care Trial in Xinjiang (HSK3486, Propofol)

Completed

Sedation in Intensive Care

Xinjiang, China

The First Affiliated Hospital of Xinjiang Medical University

May 25, 2022

Sedation in Intensive Care Trial in Guangzhou (HSK3486, Propofol)

Completed

Sedation in Intensive Care

Guangzhou, China

The First Affiliated Hospital of Sun Yat-sen University

May 25, 2022

Sedation in Intensive Care Trial in Worldwide (Clonidine, Midazolam)

Terminated

Sedation in Intensive Care

Prague, Czechia
+9 more

Jan 7, 2019